Why EVO Implantable Contact Lenses (ICL) Are Surging as the Go-To Alternative for Vision Correction.

I have been blessed to help people get out of their glasses and contact lenses for over 25 years. There has been so much progress in that time in every aspect of the treatment, as well as brand new technologies we couldn’t have conceived of 25 years ago. In this blog post, I will try to answer the question: is LASIK still the best fix in 2026, or is something better emerging? As a refractive surgery specialist here in the Pacific Northwest, I’ve seen patient preferences shift dramatically. LASIK volumes have dropped 10-15% in recent years, according to industry data from EyeWorld and the Refractive Surgery Council. This decline isn’t because vision correction is out of favor; overall refractive procedures are holding steady or growing, thanks to rising alternatives like the lens-based options EVO ICL, refractive lens exchange (RLE), and premium IOL. LASIK is no longer one-size-fits-all. The EVO ICL (Implantable Contact Lens) is exploding in popularity. The global implantable collamer lens market is projected to grow from $0.4 billion in 2025 to $1.3 billion by 2035. In the U.S., EVO ICL sales are surging as patients seek options for high prescriptions, thin corneas, or fewer side effects like dry eyes — a big concern in our dry indoor winters.

Both LASIK and EVO ICL deliver life-changing vision correction, but EVO ICL’s reversibility, lower dry eye risk, speed and ease of performing the procedure, accuracy of the lens and stability of vision, and superior night vision for certain patients are making it the premium choice for many more people in 2026. LASIK, however, is still a superb choice for low to moderate degrees of nearsightedness and astigmatism. Additionally, LASIK can correct irregular corneas with wavefront guided treatments that are not possible with the EVO ICL. Here’s a head-to-head breakdown to help you decide, based on the latest 2025-2026 studies and trends. Whether you’re in tech staring at screens all day or a lineman repairing and maintaining electrical or cable lines, understanding these options could be key to your best outcome.

At SHARPEVISION, we have been especially fortunate because we, as of 2026, do more EVO ICL implants than anyone in the USA.

What Is LASIK? A Quick Overview:

LASIK, or Laser-Assisted In Situ Keratomileusis, has been the gold standard for vision correction since the late 1990s. It works by using a femtosecond laser to create a thin flap in the cornea, then an excimer laser reshapes the underlying tissue to correct refractive errors like myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. In 2026, advancements like wavefront-guided and topography-guided systems (e.g., Contoura) have improved the quality of vision even more, with FDA studies showing 96% patient satisfaction and over 90% achieving 20/20 or better vision.

LASIK is quick, painless, and has a proven long-term track record. The procedure takes about 3 minutes per eye, and most patients see better than 20/20 the next day, although the vision is still foggier on day one than it will ultimately be. It’s ideal for stable, moderate prescriptions with adequate corneal thickness, with proven results for over 25 years.

What Is EVO ICL? A Quick Overview:

EVO ICL takes a different approach: Instead of reshaping the cornea, it involves implanting a thin, biocompatible collamer (a combination of porcine collagen and synthetic material that has a 30+ year track record of stability in the eye) lens behind the iris and in front of your natural lens through a tiny incision. This additive method corrects vision without removing tissue.

The EVO model, available outside the US since 2011, was FDA approved in 2022.

• EVO features 5 tiny holes to allow fluid pressure to equalize on either side of the lens.
• The optic is slightly bigger than the prior “Visian” model to improve night vision (Side note: ALL US EVO ICLs are the EVO+ which has a slightly larger optic than the previous model. Staar surgical dropped the name “Plus” for the US market, but it is the larger optic up until -12. For lenses higher than -12, the optic diameter is reduced to the same size as the prior Visian model because it’s too thick to make larger.
• Treats high myopia (up to -15 diopters) with or without astigmatism up to 4 diopters. I have treated people with even higher prescriptions using LASIK to treat any residual nearsightedness and astigmatism.
• Procedure time: slightly longer than LASIK, about 5-7 minutes per eye, for a total of about 20 minutes lying flat on the chair including the prep.
• Recovery is similar to LASIK, where you will likely have 20/20 vision the next day, but it’s still fairly foggy especially around lights at night time. That improves for at least 6 to 8 weeks.
• EVO ICL can be removed or exchanged if needed. In my practice I have only removed the lens from two people out of over 2000 people because they were dissatisfied with their night vision. Both had very high prescriptions and 20/15 excellent daytime vision. Occasionally, we need to exchange the lens for one that is bigger or smaller. In my hands, this has been about one in 400 lenses. Not often, and it’s fairly easy to do, but better measurement techniques and experience are reducing this likelihood even more.
• The EVO ICL is gaining traction globally, with over 3 million implanted worldwide. At SHARPEVISION, we have been especially fortunate because we, as of 2026, do more EVO ICL implants than anyone in the USA. I believe this is because in Seattle we have a large Chinese and Asian population where EVO ICL is done in about 80% of people choosing refractive surgery . For Seattleites with high prescriptions or dry eye histories from our variable climate, this is often a game-changer. So many of our patients were not LASIK candidates because of their high prescription. I recommend EVO ICL for anyone over -3.00 units of nearsightedness.

Head-to-Head Comparison

To make it clear, here’s how they stack up based on 2025-2026 data:

Pros and Cons of Each

LASIK’s pros are undeniable: It’s fast, painless, and easy with over a quarter century track record and vast surgeon experience — over 40 million procedures worldwide. Recovery is rapid, allowing most patients to drive the next day and return to all activities. I council my patients that they can return to exercise, screen time, bathing, and travel the next day, if they want. I say, “just get the drops in and don’t get poked in the eye“. Modern tech minimizes risks, and it’s great for standard cases. However, cons include a moderate dry eye risk (affecting up to 30% initially), and potential need for touch-ups (enhancement surgery) over 10 to 20 years.

EVO ICL shines with no induced dry eye, better night vision quality (less halos and starbursts, per studies showing quicker adaptation), and built-in UV protection. It’s reversible, does not affect the cornea in strength or dryness, and excels in high myopia where LASIK might not qualify you. I believe that as long as we can measure accurately, that the EVO ICL is 100% accurate. I have had a couple patients need a touchup afterward, but even the long-term stability seems to be about 98% in 10 years. Downsides? Higher cost (our current fee is $3798/eye for -8.00 and under, $4798/eye for over -8.00), a slightly longer initial recovery (vision improves for probably six or eight weeks, but is functional to drive and work the next day), and small added risks like lens rotation necessitating a lens exchange (rare, <1%). Not as many surgeons offer the EVO ICL, but at SHARPEVISION, we are currently the most experienced in the country

Who Should Choose Which? A Candidacy Guide:

The short answer is: come to SHARPEVISION for your free consultation, and we will go over all the reasons for making our recommendation based on your specific needs and preferences. Choosing depends on your eyes and lifestyle. Opt for LASIK if you have a moderate prescription, good corneal thickness, and no major dry eye history. That said, I believe “dry eyes“ in young people is almost always misdiagnosed contact lens intolerance. Lasik is perfect for busy professionals needing immediate results.

Go for EVO ICL if you have high myopia, thin corneas, or dry eyes are a concern; if you have large pupils affecting night driving; or if reversibility appeals (e.g., younger patients). Seattle’s active scene — hiking, water sports — favors EVO ICL’s durability, as there’s no flap to worry about. A thorough pre-op exam (including topography and pupil measurement) is essential; not everyone qualifies. In my practice, about 20% of LASIK candidates switch to EVO ICL after screening.

What Recent Trends & Studies Say (2025–2026)

LASIK’s decline (10-15% volume drop) is offset by EVO ICL’s surge, driven by better outcomes for high myopes. AAO 2025 sessions highlighted EVO ICL’s reversibility and superior nighttime vision for prescriptions beyond -6D. Studies show 93.3% vision improvement with EVO ICL vs. 88.3% for LASIK in myopia cases. Both boast >95% satisfaction, but EVO ICL fills gaps where LASIK risks ectasia or dry eyes.

Recovery & Lifestyle After Surgery

LASIK recovery: Most see 20/15 at the postoperative day number one visit, but there’s still some fogginess at night; avoid rubbing eyes indefinitely, which is always good advice. There is adequate evidence that vigorous chronic eye rubbing can stretch the cornea which makes you not a candidate for any procedure. This condition is called corneal ectasia, a subset of which is called keratoconus.

EVO ICL: Functional vision in days, full clarity in 1-2 weeks; similar restrictions but longer eye drops. Long-term, both are excellent, but EVO ICL may edge out for night activities.

Cost, Risks, and Next Steps

Costs: LASIK averages $2,000-3,500 per eye; EVO ICL $4,000-6,000+, with financing common. Risks are low for both (infection <1%); EVO ICL adds rare lens issues. The best choice is personalized — schedule a free refractive consultation with SHARPEVISION.

Conclusion

LASIK remains the gold standard for many, but EVO ICL’s advantages in 2026 make it the rising star for specific needs. Don’t settle — get your consultation scheduled at SHARPEVISION Bellevue, Renton, Austin, Lakeway TX, or Chicago at: sharpe-vision.com to see which choice can get you the clearest vision. The right procedure can transform your life!